Search
Aspire Biopharma Holdings Inc
ASBPAdd to Watchlist
6.680USD
-0.040-0.60%
Close 07-31 16:00（ET）Quotes delayed by 15 min
590.08KMarket Cap
LossP/E TTM
ASBP Financials
See Aspire Biopharma Holdings Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Aspire Biopharma Holdings Inc Earnings Date
Latest Release
May 15, 2026
EPS / Forecast
-20.57/--
Revenue / Forecast
28.35K/--
Period
FY2025 Earnings
Revenue(YoY)
6.20K
--
EPS(YoY)
-491.27
-707.60%
Analyst Rating
--
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What is the total revenue of Aspire Biopharma Holdings Inc?
According to Aspire Biopharma Holdings Inc's FY2025 earnings report, its total revenue reached 6.20K, with a year-on-year change of 6.20K.
What are the current assets of Aspire Biopharma Holdings Inc?
According to Aspire Biopharma Holdings Inc's FY2025 earnings report, its current assets were 1.31M, with a year-on-year change of 2762.37.
What are the total assets of Aspire Biopharma Holdings Inc?
According to Aspire Biopharma Holdings Inc's FY2025 earnings report, its total assets of Aspire Biopharma Holdings Inc were 1.31M, with a year-on-year change of -80.46.
What are the total liabilities of Aspire Biopharma Holdings Inc?
According to Aspire Biopharma Holdings Inc's FY2025 earnings report, its total liabilities of Aspire Biopharma Holdings Inc were 7.69M, with a year-on-year change of -50.77.
What is the total equity of Aspire Biopharma Holdings Inc?
According to Aspire Biopharma Holdings Inc's FY2025 earnings report, its total equity of Aspire Biopharma Holdings Inc was -6.38M, with a year-on-year change of 28.37.
What is the net operating income of Aspire Biopharma Holdings Inc?
According to Aspire Biopharma Holdings Inc's FY2025 earnings report, its net operating income of Aspire Biopharma Holdings Inc was -19.35M, with a year-on-year change of -526.52.
What is the net financing of Aspire Biopharma Holdings Inc?
According to Aspire Biopharma Holdings Inc's FY2025 earnings report, its net financing of Aspire Biopharma Holdings Inc was 5.92M, with a year-on-year change of 150.52.
What is the Earnings Per Share (EPS) of Aspire Biopharma Holdings Inc?
According to Aspire Biopharma Holdings Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -491.27, with a year-on-year change of -707.60.
What is the net income of Aspire Biopharma Holdings Inc?
According to Aspire Biopharma Holdings Inc's FY2025 earnings report, its net income was -24.48M, with a year-on-year change of -95.26.
What is the debt-to-asset ratio of Aspire Biopharma Holdings Inc?
According to Aspire Biopharma Holdings Inc's FY2025 earnings report, its debt-to-asset ratio was 394.41, with a year-on-year change of 86.14.
What is the Return on Assets (ROA) of Aspire Biopharma Holdings Inc?
According to Aspire Biopharma Holdings Inc's FY2025 earnings report, its Return on Assets (ROA) was -610.00, with a year-on-year change of -549.45.
What is the operating profit of Aspire Biopharma Holdings Inc?
According to Aspire Biopharma Holdings Inc's FY2025 earnings report, its operating profit was -19.35M, with a year-on-year change of -526.52.